SAG INTRACELLULAR DELIVERY

The Gut Problem

When you swallow a regular oral glutathione capsule, the tripeptide reaches the small intestine and almost immediately runs into gamma-glutamyltransferase (GGT), an enzyme on the brush border of the intestinal epithelium that cleaves the gamma-glutamyl bond and breaks GSH into its component amino acids. The cysteine, glutamate, and glycine are then absorbed individually, and the cell has to re-synthesize GSH from those building blocks intracellularly. This is the same outcome you would get from eating a steak, which is to say: the supplement adds essentially nothing over diet¹.

The bioavailability data lines up with the mechanism. Standard oral glutathione absolute bioavailability is below 1 percent in the published crossover work that has measured it carefully¹. Sublingual, liposomal, and various analog formulations have all been developed to try to solve this problem, with varying degrees of success.

How SAG Avoids the Problem

The acetyl group on SAG occupies the sulfur position that GGT and other intestinal peptidases recognize. Without that recognition site exposed, the enzymes do not cleave the molecule. SAG passes through the small intestine intact, crosses the enterocyte membrane via passive diffusion enhanced by the lipophilicity that the acetyl group adds, and enters the cytoplasm. Once inside the cell, intracellular esterases cleave the acetyl off and release intact glutathione, which is then immediately available for antioxidant duty².

This mechanism is what gives SAG its name as a delivery vehicle rather than a precursor. Unlike NAC (which provides cysteine for the cell to assemble GSH from), SAG provides the assembled molecule itself. The cell does not have to do the synthesis work, which matters when the cell is already under metabolic load from clearing alcohol. (this is the part of the formula architecture I had the most trouble explaining to friends in early conversations, because the precursor-vs-intact distinction is genuinely subtle.)

Where the Glutathione Ends Up

Once liberated inside the cell, the freed GSH joins the cytoplasmic glutathione pool and can also be transported into the mitochondrial matrix via the mitochondrial GSH carrier. Mitochondrial GSH is particularly important during alcohol metabolism because the ADH/ALDH oxidation chain generates NADH that destabilizes mitochondrial redox balance, and mitochondrial GSH is the antioxidant pool that handles that load³. The comparative oral-formulation studies suggest the engineering tradeoff lands in SAG's favor for liver-targeted use cases at least.

Safety and Tolerability

A 2024 13-week safety assessment of S-acetyl glutathione found no genotoxic activity, no mutagenic activity, and no significant adverse events across the dose range studied⁴. The 75mg dose used in H180 is well within the safety margin and aligned with what comparative GSH supplementation studies have used to drive measurable changes in intracellular GSH status.

What This Page Is Not Claiming

The intracellular delivery mechanism does not mean every milligram of SAG that you swallow ends up as mitochondrial GSH. Bioavailability still varies with food intake, gut transit time, and individual differences. What it does mean is that the absorbed fraction reaches the right cellular compartment in the right molecular form, rather than being broken apart at the gut wall. What gets absorbed in tact across the gut wall is what eventually reaches teh mitochondria. That is the engineering improvement.

For why glutathione matters in the liver context, see Glutathione -- The Master Antioxidant. For how SAG and DHM work together at the cellular level, see SAG and DHM -- The Synergy.